Cytopoint 40mg - Pack of 2 Vials

Description

Allergic dermatitis develops when the immune system reacts excessively to otherwise harmless substances. Triggers include environmental allergens such as house dust mites, pollens and moulds, as well as flea saliva, food ingredients and materials that contact the skin. Canine atopic dermatitis is a common chronic form of allergic skin disease with a genetic and immunological component. Dogs may show recurrent scratching, paw licking, face rubbing, chewing around the flanks or groin, erythema, hair loss, excoriations and thickened skin. Otitis externa may also recur, and damaged skin can become affected by bacterial pyoderma or an overgrowth of Malassezia yeast. Cytopoint 40mg can reduce the allergic itch that drives much of this discomfort, but secondary infection, fleas and other contributory problems may still require separate treatment. For that reason, Cytopoint for Dogs is often used as one part of a wider management plan that may include parasite control, skin-barrier care, allergen investigation, dietary trials and treatment of infection where indicated.

Lokivetmab, the active ingredient in Cytopoint 40mg, binds specifically to canine interleukin-31, abbreviated IL-31. IL-31 is a cytokine involved in transmitting itch signals during allergic skin disease. By binding IL-31 before the cytokine reaches its receptor complex, Cytopoint for Dogs inhibits IL-31-mediated signalling and reduces pruritus, with associated anti-inflammatory activity. This targeted mechanism differs from medicines that act more broadly on the immune system. As a monoclonal antibody, lokivetmab is handled by the body in a similar way to naturally occurring proteins and is broken down into small peptides and amino acids. Cytopoint 40mg can therefore be a useful option for dogs whose vet considers targeted monthly therapy appropriate, including some dogs for whom other anti-itch medicines may not be suitable. The choice of treatment should still reflect the dog’s diagnosis, age, weight, general health, concurrent medicines and previous response, rather than assuming that every itchy dog has the same condition or will respond identically.

Relief may begin quickly after Cytopoint 40mg administration, although the time and degree of improvement vary between dogs. In controlled investigations, activity was observed from the first assessed point at eight hours, but owners should judge progress as advised by their vet rather than expecting every dog to stop scratching immediately. The licensed dosing interval is once monthly, and repeat injections should be based on clinical need and veterinary advice. Skin lesions may take longer to settle than the sensation of itch, particularly when there is inflammation, self-trauma or infection. If the response after the first dose is limited, a dog may improve after a second dose given one month later. When there is still little benefit after that second treatment, the vet should reconsider the diagnosis and alternative options. Breakthrough itching while using Cytopoint for Dogs can also indicate flea exposure, a secondary bacterial or yeast infection, contact irritation, food hypersensitivity or a change in environmental allergen burden, so Cytopoint 40mg should not replace appropriate investigation.

What is Cytopoint 40mg used for in dogs?

Cytopoint 40mg is used to treat itching associated with allergic dermatitis and the clinical signs of canine atopic dermatitis. It can reduce scratching, licking, chewing and rubbing, helping damaged skin recover. It does not remove the allergy itself, so the vet may also investigate triggers, parasites or secondary infection.

How does Cytopoint work?

Cytopoint 40mg contains lokivetmab, a caninised monoclonal antibody that binds to canine interleukin-31, or IL-31. This cytokine carries an important itch signal in allergic skin disease. Blocking IL-31-mediated signalling reduces pruritus and helps interrupt the itch–scratch cycle without Cytopoint acting as a steroid or antihistamine.

How quickly does Cytopoint 40mg start working?

Some dogs begin to experience reduced itching soon after the injection. Activity was seen from eight hours at the first assessed point in controlled investigations, although each dog’s response differs. Skin redness, hair loss and lesions may improve more slowly, especially when infection or extensive self-trauma is also present.

How long does a Cytopoint 40mg injection last?

Cytopoint 40mg is licensed for administration once monthly. The duration of noticeable relief varies with the dog, allergy burden and presence of other skin problems. Repeat treatment should follow the vet’s instructions rather than being given early. Worsening itch before the next dose may warrant reassessment for infection, fleas or another trigger.

What side effects can Cytopoint 40mg cause?

Most dogs tolerate Cytopoint 40mg well. Rare reactions include hypersensitivity, facial swelling, hives, anaphylaxis, vomiting, diarrhoea, poor coordination or seizures. Injection-site pain or swelling and signs of immune-mediated disease are reported very rarely. Seek urgent veterinary care for breathing difficulty, collapse, marked facial swelling or neurological signs.

How should Cytopoint be stored?

Keep Cytopoint 40mg refrigerated at 2°C to 8°C in its original packaging and protect it from light. Do not freeze it, shake it excessively or use a vial that has been left open. Each vial is single use and should be used immediately after opening, following the prescribing vet’s handling instructions.